BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16516403)

  • 1. An essential requirement for osteoclasts in refined bone-like tissue reconstruction in vitro.
    Han D; Zhang Q
    Med Hypotheses; 2006; 67(1):75-8. PubMed ID: 16516403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
    Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
    Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclasts secrete non-bone derived signals that induce bone formation.
    Karsdal MA; Neutzsky-Wulff AV; Dziegiel MH; Christiansen C; Henriksen K
    Biochem Biophys Res Commun; 2008 Feb; 366(2):483-8. PubMed ID: 18068671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ionizing irradiation on formation and resorbing activity of osteoclasts in vitro.
    Scheven BA; Burger EH; Kawilarang-de Haas EW; Wassenaar AM; Nijweide PJ
    Lab Invest; 1985 Jul; 53(1):72-9. PubMed ID: 4010232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells.
    Yagi M; Miyamoto T; Sawatani Y; Iwamoto K; Hosogane N; Fujita N; Morita K; Ninomiya K; Suzuki T; Miyamoto K; Oike Y; Takeya M; Toyama Y; Suda T
    J Exp Med; 2005 Aug; 202(3):345-51. PubMed ID: 16061724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development, physiology, and cell activity of bone].
    de Baat P; Heijboer MP; de Baat C
    Ned Tijdschr Tandheelkd; 2005 Jul; 112(7):258-63. PubMed ID: 16047964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The osteoclast: a multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell.
    Bar-Shavit Z
    J Cell Biochem; 2007 Dec; 102(5):1130-9. PubMed ID: 17955494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
    Hollberg K; Marsell R; Norgård M; Larsson T; Jonsson KB; Andersson G
    Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrospun materials as potential platforms for bone tissue engineering.
    Jang JH; Castano O; Kim HW
    Adv Drug Deliv Rev; 2009 Oct; 61(12):1065-83. PubMed ID: 19646493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early scanning electron microscopic studies of hard tissue resorption: their relation to current concepts reviewed.
    Boyde A; Jones SJ
    Scanning Microsc; 1987 Mar; 1(1):369-81. PubMed ID: 3589611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cellular basis of bone resorption.
    Chambers TJ
    Clin Orthop Relat Res; 1980 Sep; (151):283-93. PubMed ID: 7418318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of partially demineralized osteoporotic cancellous bone matrix combined with human bone marrow stromal cells for tissue engineering: an in vitro and in vivo study.
    Liu G; Sun J; Li Y; Zhou H; Cui L; Liu W; Cao Y
    Calcif Tissue Int; 2008 Sep; 83(3):176-85. PubMed ID: 18704250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts.
    Vaes G
    Clin Orthop Relat Res; 1988 Jun; (231):239-71. PubMed ID: 3286076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone remodeling and the osteoclast.
    Teitelbaum SL
    J Bone Miner Res; 1993 Dec; 8 Suppl 2():S523-5. PubMed ID: 8122522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
    Hughes A; Rogers MJ; Idris AI; Crockett JC
    Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity.
    Iwasaki R; Ninomiya K; Miyamoto K; Suzuki T; Sato Y; Kawana H; Nakagawa T; Suda T; Miyamoto T
    Biochem Biophys Res Commun; 2008 Dec; 377(3):899-904. PubMed ID: 18952053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts.
    Imai Y; Youn MY; Kondoh S; Nakamura T; Kouzmenko A; Matsumoto T; Takada I; Takaoka K; Kato S
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E31-9. PubMed ID: 19751412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
    Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
    Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function].
    Takahashi N
    Clin Calcium; 2006 Jun; 16(6):940-47. PubMed ID: 16751689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.